InChI=1S/C62H109N11O13/c1-24-43-58(81)67(17)32-48(75)68(18)44(27-33(2)3)55(78)66-49(37(10)11)61(84)69(19)45(28-34(4)5)54(77)63-40(15)53(76)64-41(16)57(80)70(20)46(29-35(6)7)59(82)71(21)47(30-36(8)9)60(83)72(22)50(38(12)13)62(85)73(23)51(56(79)65-43)52-39(14)31-42(86-52)25-26-74/h26,33-47,49-52H,24-25,27-32H2,1-23H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/t39-,40+,41-,42?,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1 |
UFWMVNJLCHMUKS-JFGKHBSWSA-N |
[C@H]1(N(C([C@@H](N(C([C@@H](N(C)C([C@@H](N(C([C@H](NC([C@@H](NC([C@@H](N(C([C@@H](NC([C@@H](N(C)C(CN(C([C@@H](NC1=O)CC)=O)C)=O)CC(C)C)=O)C(C)C)=O)C)CC(C)C)=O)C)=O)C)=O)C)CC(C)C)=O)CC(C)C)=O)C)C(C)C)=O)C)[C@]2([C@H](C)CC(O2)(CC=O)[H])[H] |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
drug metabolite
|
|
View more via ChEBI Ontology
{(4R,5R)-5-[(2S,5S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-11,17,26,29-tetraisobutyl-14,32-diisopropyl-1,7,10,16,20,23,25,28,31-nonamethyl-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl]-4-methyltetrahydrofuran-2-yl}acetaldehyde
|
AM1cAL
|
ChEBI
|
cyclosporin A metabolite AM1cAL
|
ChEBI
|
cyclosporin metabolite AM1cAL
|
ChEBI
|
cyclosporin metabolite M1cAL
|
ChEBI
|
cyclosporine A metabolite AM1cAL
|
ChEBI
|
cyclosporine A metabolite M1cAL
|
ChEBI
|
cyclosporine metabolite AM1cAL
|
ChEBI
|
cyclosporine metabolite M1cAL
|
ChEBI
|
M1cAL
|
ChEBI
|
8745344
|
PubMed citation
|
Europe PMC
|
8782089
|
PubMed citation
|
Europe PMC
|
|